[Pfizer Inc.](https://www.pfizer.com)

May 5, 2026: Submission Deadline (full application submission due by 23:59 Eastern Standard Time)

Up to $50,000 per project; estimated total available budget is $100,000; project duration up to 1 year

Supports educational programs to enhance clinical trial readiness for Sickle Cell Disease by training multidisciplinary healthcare professionals and building internal research infrastructure.

--- ## Description This grant opportunity, offered by Pfizer Inc., is designed to strengthen clinical trial readiness for Sickle Cell Disease (SCD) in the United States. The program focuses on supporting educational initiatives that prepare multidisciplinary healthcare teams—including physicians, advanced practice providers, nurses, research coordinators, and pharmacists—to effectively participate in SCD clinical trials. Key priorities include developing internal research infrastructure, standardizing trial workflows, improving feasibility and startup processes, fostering coordination between clinical care and research teams, reducing operational barriers, and promoting culturally responsive, patient-centric research engagement. Projects may also address decentralized clinical trial education, the implementation of new technologies (such as AI), and education on SCD-specific challenges and barriers. --- ## Due Dates - May 5, 2026: Submission Deadline (applications due by 23:59 Eastern Standard Time) Anticipated grant award notification: June 19, 2026 Anticipated project start: September 2026 Anticipated project end: September 2027 --- ## Funding Amount - Individual projects may request up to $50,000 USD. - The estimated total available budget for this RFP is $100,000 USD. - Maximum project duration is 1 year. - Award amounts include direct costs, institutional overhead (capped at 28%), and indirect costs. --- ## Eligibility - Projects must be conducted in the United States. - Eligible applicants include: - Medical, nursing, allied health, and pharmacy professional schools - Healthcare institutions (large and small) - Patient advocacy groups - Professional organizations/medical societies - Medical education companies - Other entities with a mission related to healthcare professional education or improvement - Only organizations are eligible (not individuals or unaffiliated medical practice groups). - The applicant must be the project/program lead or an authorized designee and must be an employee or contractor of the requesting organization. - The requesting organization must be legally able to receive funds directly from Pfizer Inc. - For projects offering continuing education credit, the organization must be accredited. - Both accredited and non-accredited proposals are eligible. - Clinical research projects or those evaluating the efficacy of therapeutic or diagnostic agents will NOT be considered. --- ## Application Process - Applications must be submitted online at [www.cybergrants.com/pfizer/knowledge](http://www.cybergrants.com/pfizer/knowledge). - Select “Start A New Knowledge Gap Application.” - For “Competitive Grant?” select “Yes.” - Select the Primary Area of Interest: “Genetics - Sickle Cell Disease - KG.” - Select the Competitive Grant Program Name: “2026 RD US Trial Training SCD IME.” - Upload a proposal (max 15 pages, single-spaced, Calibri 12, 1-inch margins) addressing: - Goals and objectives - Needs assessment - Target audience - Project design and methods - Innovation - Evaluation and outcomes - Dissemination plan - Project timeline - Organizational detail and partner roles - Budget detail (overhead up to 28%) - Required documents: Project plan/proposal, budget narrative. - Late applications will not be reviewed. --- ## Additional Information - Pfizer will not be involved in project development or conduct of the educational program. - Grant agreements are required and subject to Pfizer’s standard terms. - Only organizations able to directly receive funding from Pfizer Inc. are eligible. - Projects should focus on education, not clinical research or drug/device evaluation. --- ## External Links - [Pfizer Inc. Homepage](https://www.pfizer.com) - [Full RFP Document (PDF)](https://cdn.pfizer.com/pfizercom/2026-03/2026-RD-US-TrialTrainingSCD-IME.pdf?VersionId=SeLNdDVYjoyc.840B9xcAdO.s9Arf.TW) - [CyberGrants Application Portal](http://www.cybergrants.com/pfizer/knowledge) --- ## Contact Information | Contact | Email | Phone | Additional Info | |---------------------------|---------------------------------------------------|-----------------|------------------------------| | Talita Honorato-Rzeszewicz (Grant Officer) | [Talita.honorato-rzeszewicz@pfizer.com](mailto:Talita.honorato-rzeszewicz@pfizer.com) | 1-800-879-3477 | Subject: “2026 RD US Trial Training SCD IME” | | Pfizer General Contact | — | 1-800-879-3477 | [Pfizer Contact Page](https://www.pfizer.com/contact) | ---

Pfizer Independent Medical Education Grant Request for Proposals: Capacity Building for Clinical Trials in Sickle Cell Disease (SCD) - Education for Healthcare Professionals

Sign in to see full grant listing